Laurus Labs

Ramco Cements, Persistent Systems, Coforge, Laurus Labs and HDFC Bank Shares in Focus After Bullish Price Action

Ramco Cements, Persistent Systems, Coforge, Laurus Labs and HDFC Bank Shares in Focus After Bullish Price Action

Ramco Cements, Persistent Systems, Coforge, Laurus Labs and HDFC Bank Shares witnessed strong bullish momentum on the weekly technical charts.

GNFC, Laurus Labs, Chambal Fertilisers, Ramco Cements Share Price Firm; Technical Analysis and Bullish Breakout Review

GNFC, Laurus Labs, Chambal Fertilisers, Ramco Cements Share Price Firm; Technical Analysis and Bullish Breakout Review

GNFC, Laurus Labs, Chambal Fertilisers, Ramco Cement shares were trading positive among mid-cap stocks.

Laurus Labs Share Price Touches 52-week high; Technical Charts Suggest Bullish Breakout

Laurus Labs Share Price Touches 52-week high; Technical Charts Suggest Bullish Breakout

Laurus Labs shares were trading firm in early trades. The stock touched 52-week high today and is currently trading 1.2 percent higher.

Laurus Labs Share Price Close to Yearly Highs; Fibonacci Levels & Technical Analysis Suggest Bullish Breakout

Laurus Labs Share Price Close to Yearly Highs; Fibonacci Levels & Technical Analysis Suggest Bullish Breakout

Laurus Labs, a major player in the pharmaceutical and biotechnology space, has been gaining traction among investors due to its strong fundamentals and sectoral potential.

Laurus Labs Share Price Jumps 2 Percent; KRChoksey downgrades to Accumulate Citing Lower than Expected Quarterly Performance

Laurus Labs Share Price Jumps 2 Percent; KRChoksey downgrades to Accumulate Citing Lower than Expected Quarterly Performance

KRChoksey has downgraded its stance on Laurus Labs to "ACCUMULATE" from "BUY," with a revised target price of Rs 489, implying a modest 5.4% upside from the current price of Rs 464.

Laurus Labs Jumps 4.4 Percent As US Government Passes Biosecure Act

Laurus Labs Jumps 4.4 Percent As US Government Passes Biosecure Act

Laurus Labs' share price surged by 4%, trading at Rs 510.5, reflecting a broader rally in Indian pharmaceutical stocks following the U.S. House of Representatives' passing of the Biosecure Act.

Pages